Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05544734 · ClinicalTrials.gov registry record · Phase 4
Hydrocodone Compared to Acetaminophen and Ibuprofen for Post-nail Procedure Analgesia
A Phase 4 study, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT05544734 is a Phase 4 study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 20 participants.
The verdict
NCT05544734, a Phase 4 study, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the safety and efficacy of ropivacaine and hydrocodone for nail-procedure associated pain management. The investigators hypothesize that ropivacaine with hydrocodone will be superior to ropivacaine with acetaminophen and ibuprofen for managing pain.
Interventions
- DRUG Hydrocodone 5Mg/Acetaminophen 325Mg Tab
- DRUG Ibuprofen 400 mg
- DRUG Acetaminophen 1000mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-11-10 |
| Est. Completion | 2023-06-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05544734
The ClinicalTrials.gov registry entry for NCT05544734 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Hydrocodone 5Mg/Acetaminophen 325Mg Tab is the first listed.
NCT05544734 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05544734 about?
NCT05544734 is a clinical study titled "Hydrocodone Compared to Acetaminophen and Ibuprofen for Post-nail Procedure Analgesia". The purpose of this study is to assess the safety and efficacy of ropivacaine and hydrocodone for nail-procedure associated pain management. The investigators hypothesize that ropivacaine with hydrocodone will be superior to ropivacaine with acetaminophen and ibuprofen for managing pain.
What is the current status of trial NCT05544734?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2022-11-10. Estimated completion is 2023-06-01.
What interventions are being tested in trial NCT05544734?
The interventions under investigation include: Hydrocodone 5Mg/Acetaminophen 325Mg Tab (DRUG), Ibuprofen 400 mg (DRUG), Acetaminophen 1000mg (DRUG).
Who is sponsoring clinical trial NCT05544734?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.